نتائج البحث - Charles Landis

  • يعرض 1 - 19 نتائج من 19
تنقيح النتائج
  1. 1
    Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report

    Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report حسب Alexander R. Ende, Nina H. Kim, Matthew M. Yeh, Jason Harper, Charles Landis

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The hepatic stem cell niche: Identification by label-retaining cell assay

    The hepatic stem cell niche: Identification by label-retaining cell assay حسب Reiichiro Kuwahara, Alexander Kofman, Charles Landis, Scott Swenson, E Barendswaard, Neil D. Theise

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change

    Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change حسب Catherine E. Kling, James D. Perkins, Charles Landis, Ajit P. Limaye, Lena Sibulesky

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo

    Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo حسب Charles Landis, Xin Li, Frank Telang, Patricia E. Molina, Ildikó Pályka, Gábor Vétek, Charles S. Springer

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit

    Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit حسب Feng Su, Lei Yu, Kristin Berry, Iris Liou, Charles Landis, Stephen C. Rayhill, Jorgé Reyes, George N. Ioannou

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals

    Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals حسب Mignote Yilma, Nicole J. Kim, Amy M. Shui, Michele Tana, Charles Landis, Ariana Chen, Saroja Bangaru, Neil Mehta, Kali Zhou

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis

    Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis حسب George N. Ioannou, Charles Landis, Ga‐Young Jin, W. Geoffrey Haigh, Geoffrey C. Farrell, Rahul Kuver, Sum P. Lee, Christopher E. Savard

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

    Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence حسب Fred Poordad, Eugene R. Schiff, John M. Vierling, Charles Landis, Robert J. Fontana, Rong Yang, Fiona McPhee, Eric Hughes, Stephanie Noviello, Eugene Swenson

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States

    Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States حسب Michael Fried, Julie M. Crawford, Andrea R. Mospan, Stephanie Watkins, Breda Muñoz, Richard C. Zink, Sherry Elliott, Kyle Burleson, Charles Landis, K. Rajender Reddy, Robert S. Brown

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment

    Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment حسب Fred Poordad, Franco Felizarta, Armen Asatryan, Mark Sulkowski, Robert Reindollar, Charles Landis, Stuart C. Gordon, Steven L. Flamm, Michael Fried, David Bernstein, Chih‐Wei Lin, Ran Liu, Sandra Lovell, Teresa I. Ng, Jens Kort, Federico Mensa

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

    DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort حسب Elizabeth C. Verna, Giuseppe Morelli, Norah A. Terrault, Anna S. Lok, Joseph K. Lim, Adrian M. Di Bisceglie, Stefan Zeuzem, Charles Landis, Paul Y. Kwo, Mohamed A. Hassan, Michael P. Manns, Monika Vainorius, Lucy Akushevich, David R. Nelson, Michael Fried, K. Rajender Reddy

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

    Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial حسب Gideon M. Hirschfield, Olivier Chazouillères, Joost P.H. Drenth, Douglas Thorburn, Stephen A. Harrison, Charles Landis, Marlyn J. Mayo, Andrew J. Muir, James F. Trotter, Diana Julie Leeming, M.A. Karsdal, Mark Jaros, Lei Ling, Kathline H. Kim, Stephen J. Rossi, R. Somaratne, Alex M. DePaoli, Ulrich Beuers

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

    The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis حسب Michael Trauner, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, Kosh Agarwal, Andrew J. Muir, Simon Rushbrook, Xiaomin Lu, Jun Xu, Jen‐Chieh Chuang, Andrew N. Billin, Georgia Li, Chuhan Chung, G. Mani Subramanian, Robert P. Myers, Christopher L. Bowlus, Kris V. Kowdley

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease حسب Michael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis, Robert S. Brown, Michael Fried, Norah A. Terrault, Jacqueline G. O’Leary, Hugo E. Vargas, Alexander Kuo, Eugene R. Schiff, Mark Sulkowski, Richard Gilroy, Kymberly D. Watt, Kimberly Brown, Paul Y. Kwo, Surakit Pungpapong, Kevin Korenblat, Andrew J. Muir, Lewis Teperman, Robert J. Fontana, Jill Denning, Sarah Arterburn, Hadas Dvory‐Sobol, T. Brandt-Sarif, Phillip S. Pang, John G. McHutchison, K. Rajender Reddy, Nezam H. Afdhal, Princy Kumar, Eugene R. Schiff, Nezam H. Afdhal, R. S. Brown, Michael Fried, Kris V. Kowdley, Norah A. Terrault, Michael Charlton, Paul Y. Kwo, S. Flamm, John R. Lake, G. Everson, Mark Sulkowski, Michael P. Curry, Rajender Reddy, Lewis Teperman, Hugo E. Vargas, Surakit Pungpapong, Andrew J. Muir, Atif Zaman, Kimberly Brown, Charles Landis, Alexander Kuo, Robert J. Fontana, Jacqueline G. O’Leary, Richard Gilroy, Obaid S. Shaikh, Kevin Korenblat, Richard T. Stravitz, Kymberly D. Watt, Narayanan Menon, James E. Bredfeldt, Carlos Romero‐Marrero

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

    Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection حسب Marc Bourlière, Stuart C. Gordon, Steven L. Flamm, Curtis Cooper, Alnoor Ramji, Myron J. Tong, Natarajan Ravendhran, Simon C. Ling, Tram T. Tran, Stephen Pianko, Meena B. Bansal, Victor de Lédinghen, Robert H. Hyland, Luisa M. Stamm, Hadas Dvory‐Sobol, Evguenia S. Svarovskaia, Jie Zhang, Kaijiao Huang, G. Mani Subramanian, Diana M. Brainard, John G. McHutchison, Elizabeth C. Verna, Peter Buggisch, Charles Landis, Ziad Younes, Michael P. Curry, Simone I. Strasser, Eugene R. Schiff, K. Rajender Reddy, M.P. Manns, Kris V. Kowdley, Stefan Zeuzem

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial

    Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial حسب Julie Thompson, Natasha Jones, Ali Al‐Khafaji, Shahid M. Malik, David J. Reich, Santiago J. Muñoz, Ross MacNicholas, Tarek Hassanein, Lewis Teperman, Lance L. Stein, Andrés Duarte‐Rojo, Raza Malik, Talal Adhami, Sumeet K. Asrani, Nikunj Shah, Paul J. Gaglio, Anupama Duddempudi, Brian B. Borg, Rajiv Jalan, Robert S. Brown, Heather Patton, Rohit Satoskar, Simona Rossi, Amay Parikh, Ahmed M. Elsharkawy, Parvez Mantry, Linda Sher, David C. Wolf, Marquis Hart, Charles Landis, Alan Wigg, Shahid Habib, Geoffrey W. McCaughan, Steven D. Colquhoun, A. D. Henry, Patricia W. Bedard, Lee K. Landeen, J. Michael Millis, Robert Ashley, William A. Frank, Andrew Henry, Jan Stange, Ram Subramanian

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

    Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis حسب Marlyn J. Mayo, Elizabeth J. Carey, Helen T. Smith, Andrea R. Mospan, Megan McLaughlin, April Thompson, Heather Morris, Robert Sandefur, W. Ray Kim, Christopher L. Bowlus, Victor Ankoma‐Sey, David I. Bernstein, Brian B. Borg, Christopher L. Bowlus, Robert Brown, Elizabeth J. Carey, Virginia Clark, Jama M. Darling, Jonathan A. Dranoff, Hany Elbeshbeshy, Lisa Forman, Aparna Goel, James Hanje, Stephen A. Harrison, Sujit Janardhan, Randhir Jesudoss, David Kim, Lindsay Y. King, Charles Landis, Cynthia Levy, Anna Lok, Michael R. Lucey, V LUKETIC, Richard Manch, W. van der Mark, Marlyn J. Mayo, Edward Mena, Apurva A. Modi, Gautham P. Reddy, K. Rajender Reddy, Fedja A. Rochling, Sergio Rojter, Raymond A. Rubin, Mark Russo, Mitchell Shiffman, Marina G. Silveira, Carmen Stanca, Paul J. Thuluvath, Elizabeth C. Verna, Laurence Weiss, Cynthia Levy

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation

    Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation حسب Aldo J. Montaño‐Loza, Ellina Lytvyak, Gideon M. Hirschfield, Bettina E. Hansen, Maryam Ebadi, Thierry Berney, Christian Toso, Giulia Magini, Alejandra Villamil, Frederik Nevens, Natalie Van den Ende, Albert Pares, Pablo Ruiz, Débora Terrabuio, Palak J Trivedi, Nadir Abbas, Maria Francesca Donato, Lei Yu, Charles Landis, Jérôme Dumortier, Jessica Dyson, Adriaan J. van der Meer, Rozanne de Veer, Mark Pedersen, Marlyn J. Mayo, Michael P. Manns, Richard Taubert, Theresa A. Kirchner, L Belli, Chiara Mazzarelli, Guido Stirnimann, Annarosa Floreani, Nora Cazzagon, Francesco Paolo Russo, Patrizia Burra, Udi Zigmound, Inbal Houri, Marco Carbone, Giacomo Mulinacci, Stefano Fagiuoli, Daniel S. Pratt, Alan Bonder, Thomas D Schiano, Brandy Haydel, Ansgar W. Lohse, Christoph Schramm, Darius F. Rüther, Stefania Casu, Xavier Verhelst, Benedetta Terziroli Beretta-Piccoli, Mercedes Robles‐Díaz, Andrew L Mason, Christophe Corpechot

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

    Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension حسب Guadalupe Garcı́a-Tsao, Jaime Bosch, Zeid Kayali, Stephen A. Harrison, Manal F. Abdelmalek, Eric Lawitz, Sanjaya K. Satapathy, Marwan Ghabril, Mitchell L. Shiffman, Ziad Younes, Paul J. Thuluvath, Annalisa Berzigotti, Agustı́n Albillos, James M. Robinson, David Hagerty, Jean L. Chan, Arun J. Sanyal, Manal F. Abdelmalek, K.R. Bhamidimarri, Brian B. Borg, Stephen H. Caldwell, Jonathan M. Fenkel, B. Freilich, Michael Fuchs, Marwan Ghabril, R. Ghalib, Stevan A. Gonzalez, Sonya G. Gordon, Bilal Hameed, Stephen A. Harrison, Zeid Kayali, Nyingi Kemmer, Kevin Korenblat, Ming‐Zong Lai, Charles Landis, E.J. Lawitz, William M. Lee, Steven D. Lidofsky, Edward Mena, Mazen Noureddin, Angelo H. Paredes, Nikolaos Pyrsopoulos, K. Rajender Reddy, M. Rinella, Don C. Rockey, Manuel Rodríguez, Michele B. Ryan, Souvik Sarkar, Sanjaya K. Satapathy, Andrew Scanga, Mitchell L. Shiffman, Mohammad Shadab Siddiqui, Douglas A. Simonetto, Wing-Kin Syn, Paul J. Thuluvath, Ramesh Vemulapalli, John M. Vierling, Ziad Younes, Agustı́n Albillos, Juan Arenas Ruiz-Tapiador, Salvador Augustín, José Luís Calleja, Javier Crespo, L. García Buey, Juan Carlos García‐Pagán, Cándid Villanueva, C. Bureau, N. Carbonell, Valériane Leroy, Pierre‐Emmanuel Rautou, HS Heinzow, Ingolf Schiefke, Alexander Zipprich, Annalisa Berzigotti, Beat Muellhaupt

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: